Healthcare professional reported that a patient was injected with juvéderm® voluma¿ xc in midface and chin with juvéderm® vollure¿ xc in perioral creases.
Three days later, patient complained of swelling and blisters, which further noted as "artial occlusion.
" that same day, nurse practitioner administered 12 vials of hylenex and another 6 vials of hylenex under guided ultrasound the next day.
This is the same event and the same patient reported under mdr id # 3005113652-2022-00081 (allergan complaint #(b)(4)).
This mdr is being submitted for the suspect product, juvéderm® vollure¿ xc.
|
Further information regarding event, product, or patient details has been requested.
No additional information is available at this time.
The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.
The filler was injected into the patient and is not accessible for return.
The syringe was not returned for evaluation.
This is a known potential adverse event addressed in the product labeling.
|